<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000269426">
  <TermName>pyroxamide</TermName>
  <TermPronunciation>(py-ROK-suh-mide)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called histone deacetylase inhibitors.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000709963" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pyroxamide&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000709962" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;piroxamida&quot;" language="es" id="_4"/>
  <SpanishTermName>piroxamida</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Pertenece al tipo de medicamentos llamados inhibidores de la histona–desacetilasa.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2002-12-21</DateFirstPublished>
  <DateLastModified>2005-03-02</DateLastModified>
</GlossaryTerm>
